Figure. 1. Flow chart of the trial selection process and classification.
Table1. The clinical studies of ORS
Table2. The clinical studies of ORS used for Head diseases
Table3. The clinical studies of ORS used for Urinary system diseases
Table4. The clinical studies of ORS used for Edema
Table5. The clinical studies of ORS used for Adjuvant
Table6. The clinical studies of ORS used for Others
참고문헌
- Moon JJ, Ahn GS, Kim SH, Park JH, Kim DH, Choi DY, et al. ShangHanLunJeongHae. Seoul:Publicaton HanEuiMunHwaSa. 2010: 176-82, 329.
- Lee SI, Cho HR. The Comparisons of Shanghanlun. Korean Medical Association of clinical Sanghan-Geumgwe. 2015:203
- Kook YB, Kim SC, Park SD, Park SK, Seo BI, Seo YB, Shin SS, Lee SI, Lee JC, Lee KH, Jeong JG, Ju YS, Choi HY. Formula Study. Seoul:Younglimsa. 2006:504-5.
- Otsuka K. Explanation in Symptomatical Practice of Kampo-Medicine. Wonju:Euibangseolim. 2013:27, 34, 69.
- The society of Korean Medicine. EvidenceBased of Korean Medicine Treatment. Seoul. Publicaton Gunja. 2011:2.
- The Japan Society for Oriental Medicine EBM Special Committee. Herbal Formula of EvidenceBased. Seoul. Korea Medical Book. 2004.
- Kim JH, Shin HG. Analysis of biological experiment on Oryeong-san (Wuling-san). Journal of korean oriental internal medicine. 2012;33(1):69-82.
- Park HY, Hwang YH, Ha JH, Jeong GY, Ma JY. Acute Toxicity Study on Oryeong-san in Mice. Journal of korean oriental herbal formula study. 2013;21(1):111-18. https://doi.org/10.14374/HFS.2013.21.1.111
- Bang JG. A Study on Syndromes of Oryeongsan. Journal of Oriental Medical Classics. 2007; 20(1):151-64.
- Kim HY, Ryu HY. A Literature Review on the Internal Medicine of Oryeongsan. Journal of korean oriental internal medicine. 1993;14(2):79-91.
- Jeong MJ, Gang GY, Gang JY, Yun JH, Choe YM, Kim HJ, Seon SH, Jang YS. An Overview of the Applicability of Oryung-san as an Antihypertensive Agent. Journal of korean oriental internal medicine. 2017; 38(4):443-54. https://doi.org/10.22246/jikm.2017.38.4.443
- Lee HY, Gang GY, Lee E, Lee SH, Han CH, Jang IS. A Systematic Review on Antihypertensive Effects of Oryeong-san. Journal of korean oriental internal medicine. 2013;34(3):289-97.
- David AG, Kenneth FS. an overview of clinical research:the lay of the land. The Lancet. 2002;359(9300):57-61. https://doi.org/10.1016/S0140-6736(02)07283-5
- Miyagami M, Kagawa Y. Effectiveness of Kampo medicine Gorei-San for chronic subdural hematoma. No Shinkei Geka. Neurological Surgery. 2009;37(8):765-70.
- Wakabayashi Y, Yamashita M, Asano T, Yamada A, Kenai H, Kondoh Y, Hori Y, Nagatomi H. Effect of Gorei-san with tranexamic acid for preventing recurrence of chronic subdural hematoma. No Shinkei Geka. Neurological Surgery. 2012;40(11):967-71.
- Okamura A, Kawamoto Y, Sakoda E, Murakami T, Hara T. Evaluation of recurrence factors and Gorei-san administration for chronic subdural hematoma after percutaneous subdural tapping. Hiroshima J Med Sci. 2013;62(4):77-82.
- Yasunaga H. Effect of Japanese Herbal Kampo Medicine Goreisan on Reoperation Rates after Burr-Hole Surgery for Chronic Subdural Hematoma:Analysis of a National Inpatient Database. Evid Based Complement Alternat Med. 2015;2015.
- Cho KH, Kwon S, Jung WS, Moon SK. Herbal Medicine, Oreongsan for Recurrent Chronic Subdural Hematoma:A Case Report. Explore: The Journal Of Science &Healing. 2017;13(2):139-41 https://doi.org/10.1016/j.explore.2016.12.008
- Jeong YG, Kim SB, Yang JY, Mun SG, Jeong YS, Gwon SW, Jo GH. Two Case Studies of the Use of Oreong-san for a Chronic Subdural Hematoma. Journal of korean oriental internal medicine. 2017;38(3):259-63. https://doi.org/10.22246/jikm.2017.38.2.259
- Go HY, Jeong SM, Im YM, Park JS, Jeon CY. A Case Report of Normal Pressure Hydrocephalus. Journal of korean oriental internal medicine. 2004;25(4):221-6.
- Okada K, Ishimoto S, Fujimaki Y, Yamasoba T. Trial of Chinese medicine Wu-Ling-San for acute low-tone hearing loss. ORL J Otorhinolaryngol Relat Spec. 2012;74(3):158-63. https://doi.org/10.1159/000337819
- Yoshimura K, Miyake O, Okuyama A, Yoshioka T, Honda M, Yamaguchi S, Koide T. Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine. Hinyokika Kiyo. 1998;44(1):13-6.
- Lin E, Ho L, Lin MS, Huang MH, Chen WC. Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial. fr J Tradit Complement Altern Med. 2013;10(5):199-209.
- Wu SY, Chen HY, Tsai KS, Chiang JH, Muo CH, Sung FC, Chen YH, Chen WC. Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study. Inquiry. 2016;53.
- Jeong EH, Yu JE, Choe GH, Yu DY. Four Cases Report of the Female Lower Urinary Tract Infection with Oryeong-san. The Journal Of Oriental Gynecology. 2012;25(4):134-43.
- Lin SK, Lin PH, Hsu RJ, Chuang HC, Liu JM. Traditional Chinese medicine therapy reduces the catheter indwelling risk in dementia patients with difficult voiding symptoms. J Ethnopharmacol. 2017;203:120-6. https://doi.org/10.1016/j.jep.2017.03.040
- Makimoto F, Akiyama J, Sato K, Watanabe K, Ushiroyama T. Amniotic pocket changes following Wu-Ling-San treatment for gestational edema. Am J Chin Med. 2013;41(2):293-9. https://doi.org/10.1142/S0192415X13500213
- Lee JY, Chae J, Jeong UH, Lee SG, Jeong HS. Two Cases of Cancer-induced Lymphedema Patients Treated with Oryeongsan. Journal of korean oriental internal medicine. 2013; 34(3):322-28.
- Komiyama S, Takeya C, Takahashi R, Yamamoto Y, Kubushiro K. Feasibility study on the effectiveness of Goreisan-based Kampo therapy for lower abdominal lymphedema after retroperitoneal lymphadenectomy via extraperitoneal approach. J Obstet Gynaecol Res. 2015;41(9):1449-56. https://doi.org/10.1111/jog.12721
- Yamada K, Yagi G, Kanba S. Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia:preliminary observations. Clin Neuropharmacol. 2003; 26(3):112-4. https://doi.org/10.1097/00002826-200305000-00002
- Kori K, Oikawa T, Odaguchi H, Omoto H, Hanawa T, Minami T. Go-rei-San, a Kampo medicine, reduces postoperative nausea and vomiting:a prospective, single-blind, randomized trial. J Altern Complement Med. 2013; 19(12):946-50. https://doi.org/10.1089/acm.2013.0118
- Heo J. A Case Report of Dysmenorrhea treated by Oryeong-san based on Shanghanlun provisions. Korean Medical Association of Clinical Sanghan-Geumgwe. 2014;6(1):63-70.
- Jang IS, Kim MJ, Han HJ, Jeong MJ, Gang SY. Treatment of Primary Hypertension by Oryung-san Monotherapy:a Case Report. 2014;35(1):106-10
- Park JG. A Case Report of Primary Insomnia treated by Oryeong-san decoction. Korean Medical Association of Clinical Sanghan-Geumgwe. 2015;7(1):45-52.
- Takeda N, Tanaka K, Watanabe E, Kakihara T, Watanabe M, Kawahara H. Efficacy of the traditional Japanese medicine goreisan for the resolution of spermatic cord hydrocele in children. Surg Today. 2017;48(3):175-9.
- Suzuki H, Yoshioka K, Miyano M, Maeda I, Yamagami K, Morikawa T, Okada N, Konishi Y, Imanishi M. Tubulointerstitial nephritis and uveitis (TINU) syndrome caused by the Chinese herb "Goreisan". Clin Exp Nephrol. 2009;13(1):73-6. https://doi.org/10.1007/s10157-008-0069-y
- Sahyouni R, Goshtasbi K, Mahmoodi A, Tran DK, Chen JW. Chronic Subdural Hematoma: A Historical and Clinical Perspective. World Neurosurgery. 2017;108:948-53. https://doi.org/10.1016/j.wneu.2017.09.064
- Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with "normal' cerebrospinal pressure:A treatable syndrome. New England journal of medicine. 1965;273:117-49 https://doi.org/10.1056/NEJM196507152730301
- Nassar BR, Lippa CF. Idiopathic Normal Pressure Hydrocephalus:A Review for General Practitioners. Gerontology & Geriatric Medicine. 2016:2:1-6.
- Roh KJ, Lee EJ, Park AY, Choi BI, Son EJ. Long-Term Outcomes of Acute Low-Tone Hearing Loss. Journal of Audiology and Otology. 2015;19(2):74-8. https://doi.org/10.7874/jao.2015.19.2.74
- Bullock N, Doble A, Turner W, Cuckow P. Urology - An Illustrated Color Text. Publicaton Gunja. 2010:54-9.
- Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's Internal Medicine. Seoul:MIP. 2010:2195-6.
- Korean Society of Obstetrics and Gynecology. Obstetrics. Publicaton Gunja. 2007:773,811,816.
- The Korean Society of Lymphedema. Lymphedema. Publicaton Gunja. 2012:34, 37-8, 49.
- Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. Seoul:Beommuneducation. 2014:535, 547.
- Lee HY, Kang1KW, Lee E, Lee SH, Han CH, Jang IS. A Systematic Review on Antihypertensive Effects of Oryeong-san. Korean J. Orient. Int. Med. 2013;34(3):289-97.
- Jeong MJ, Kang KW, Kang JY, Yoon JH, Choi YM, Kim HJ, Sun SH, Jang IS. An Overview of the Applicability of Oryung-san as an Antihypertensive Agent. J. Int. Korean Med. 2017;38(4):443-54. https://doi.org/10.22246/jikm.2017.38.4.443
- An HS. Hong Chang's Pediatrics. Seoul:MiRaeaen. 2012:922.
- Chang YT, Lee JY, Wang JY, Chiou CS, Chang CC. Hydrocele of the spermatic cord in infants and children:its particular characteristics. Urology. 2010;76(1):82-6. https://doi.org/10.1016/j.urology.2010.02.062
- Linda OO, Peter H, Philip IM, Alastair KD. Tubulointerstitial nephritis and uveitis (TINU) syndrome:a systematic review of its epidemiology, demographics and risk factors. Orphanet Journal of Rare Diseases. 2017;12:128. https://doi.org/10.1186/s13023-017-0677-2
- "oryeongsan." OASIS Oriental Medicine Advanced Searching Integrated System. https://oasis.kiom.re.kr/oasis/pres/prdetailView5.jsp?idx=15&selectname=null&srch_menu_nix=null(last modified Aug 6, 2018, accessed Aug 10, 2018.)